EP1071765A4 - Alk-1 reagiert auf tgf-beta und gibt die signale weiter mittels smad-1 und smad-5 - Google Patents

Alk-1 reagiert auf tgf-beta und gibt die signale weiter mittels smad-1 und smad-5

Info

Publication number
EP1071765A4
EP1071765A4 EP99912583A EP99912583A EP1071765A4 EP 1071765 A4 EP1071765 A4 EP 1071765A4 EP 99912583 A EP99912583 A EP 99912583A EP 99912583 A EP99912583 A EP 99912583A EP 1071765 A4 EP1071765 A4 EP 1071765A4
Authority
EP
European Patent Office
Prior art keywords
smad
alk
tgf
beta
reactions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99912583A
Other languages
English (en)
French (fr)
Other versions
EP1071765A1 (de
Inventor
Kohei Miyazono
Takeshe Imamura
Dijke Peter Ten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Ludwig Cancer Research
Original Assignee
Ludwig Institute for Cancer Research Ltd
Ludwig Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Ludwig Cancer Research filed Critical Ludwig Institute for Cancer Research Ltd
Priority to EP09156929A priority Critical patent/EP2078752A3/de
Publication of EP1071765A1 publication Critical patent/EP1071765A1/de
Publication of EP1071765A4 publication Critical patent/EP1071765A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP99912583A 1998-03-13 1999-03-12 Alk-1 reagiert auf tgf-beta und gibt die signale weiter mittels smad-1 und smad-5 Withdrawn EP1071765A4 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP09156929A EP2078752A3 (de) 1998-03-13 1999-03-12 ALK-1 reagiert auf TGF-beta und gibt die Signale weiter mittels SMAD-1 und SMAD-5

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3917798A 1998-03-13 1998-03-13
US39177 1998-03-13
PCT/US1999/005735 WO1999046386A1 (en) 1998-03-13 1999-03-12 ALK-1 RESPONDS TO TGF-β AND SIGNALS THROUGH SMAD-1 AND SMAD-5

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP09156929A Division EP2078752A3 (de) 1998-03-13 1999-03-12 ALK-1 reagiert auf TGF-beta und gibt die Signale weiter mittels SMAD-1 und SMAD-5

Publications (2)

Publication Number Publication Date
EP1071765A1 EP1071765A1 (de) 2001-01-31
EP1071765A4 true EP1071765A4 (de) 2003-01-15

Family

ID=21904084

Family Applications (2)

Application Number Title Priority Date Filing Date
EP09156929A Withdrawn EP2078752A3 (de) 1998-03-13 1999-03-12 ALK-1 reagiert auf TGF-beta und gibt die Signale weiter mittels SMAD-1 und SMAD-5
EP99912583A Withdrawn EP1071765A4 (de) 1998-03-13 1999-03-12 Alk-1 reagiert auf tgf-beta und gibt die signale weiter mittels smad-1 und smad-5

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP09156929A Withdrawn EP2078752A3 (de) 1998-03-13 1999-03-12 ALK-1 reagiert auf TGF-beta und gibt die Signale weiter mittels SMAD-1 und SMAD-5

Country Status (3)

Country Link
EP (2) EP2078752A3 (de)
AU (1) AU3092899A (de)
WO (1) WO1999046386A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ502058A (en) * 1999-12-23 2003-11-28 Ovita Ltd Isolated mutated nucleic acid molecule for regulation of ovulation rate
KR101536506B1 (ko) * 2005-09-07 2015-07-14 암젠 프레몬트 인코포레이티드 액티빈 수용체 유사 키나제-1에 대한 인간 모노클로날 항체
US10059756B2 (en) 2006-11-02 2018-08-28 Acceleron Pharma Inc. Compositions comprising ALK1-ECD protein
CN111518218A (zh) 2006-11-02 2020-08-11 阿塞勒隆制药公司 Alk1受体和配体拮抗剂及其用途
US8642031B2 (en) 2006-11-02 2014-02-04 Acceleron Pharma, Inc. Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof
WO2008128559A1 (en) * 2007-04-20 2008-10-30 Stichting Katholieke Universiteit Method for providing a compound capable of interfering with a distorted chondrocyte phenotype
KR20190128254A (ko) 2008-05-02 2019-11-15 악셀레론 파마 인코포레이티드 혈관신생 및 혈관주위세포 적용범위의 조정을 위한 ａｌｋ１ 길항제 기재의 방법 및 조성물
EP4688147A1 (de) 2023-04-07 2026-02-11 Diagonal Therapeutics Inc. Bispezifische agonistische antikörper gegen activin a rezeptor-ähnliches typ 1 (alk1)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007135A2 (en) * 1995-08-14 1997-02-27 Creative Biomolecules, Inc. Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994011502A2 (en) * 1992-11-17 1994-05-26 Ludwig Institute For Cancer Research Activin receptor-like kinases, proteins having serine threonine kinase domains and their use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007135A2 (en) * 1995-08-14 1997-02-27 Creative Biomolecules, Inc. Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
"Mini Review: Bone Morphogenetic Proteins (BMPs)", R&D SYSTEMS, 1999, pages 1 - 7, Retrieved from the Internet <URL:http://www.rndsystems.com/mini_review_detail_objectname_MR99_BMPs.aspx> [retrieved on 20081111] *
ATTISANO L ET AL: "IDENTIFICATION OF HUMAN ACTIVIN AND TGFBETA TYPE I RECEPTORS THAT FORM HETEROMERIC KINASE COMPLEXES WITH TYPE II RECEPTORS", CELL, CELL PRESS, CAMBRIDGE, NA, US, vol. 75, 19 November 1993 (1993-11-19), pages 671 - 680, XP000611962, ISSN: 0092-8674 *
DIJKE TEN P ET AL: "CHARACTERIZATION OF TYPE I RECEPTORS FOR TRANSFORMING GROWTH FACTOR-B AND ACTIVIN", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 264, no. 5155, 1 April 1994 (1994-04-01), pages 101 - 104, XP000561968, ISSN: 0036-8075 *
FENG X H ET AL: "A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.", THE EMBO JOURNAL. ENGLAND 1 JUL 1997, vol. 16, no. 13, 1 July 1997 (1997-07-01), pages 3912 - 3923, XP002219537, ISSN: 0261-4189 *
KRETZSCHMAR M ET AL: "SMADS: MEDIATORS AND REGULATORS OF TGF-BETA SIGNALING", CURRENT OPINION IN GENETICS & DEVELOPMENT, CURRENT BIOLOGY LTD, XX, vol. 8, no. 8, February 1998 (1998-02-01), pages 103 - 111, XP000857433, ISSN: 0959-437X *
KRETZSCHMAR M ET AL: "THE TGF-BETA FAMILY MEDIATOR SMAD1 IS PHOSPHORYLATED DIRECTLY AND ACTIVATED FUNCTIONALLY BY THE BMP RECEPTOR KINASE", GENES AND DEVELOPMENT, COLD SPRING HARBOR, NY, US, vol. 11, no. 8, 15 April 1997 (1997-04-15), pages 984 - 995, XP002911614, ISSN: 0890-9369 *
LECHLEIDER R J ET AL: "SERINE PHOSPHORYLATION, CHROMOSOMAL LOCALIZATION, AND TRANSFORMING GROWTH FACTOR-BETA SIGNAL TRANSDUCTION BY HUMAN BSP-1", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 271, no. 30, 26 July 1996 (1996-07-26), pages 17617 - 17620, XP002030329, ISSN: 0021-9258 *
PERSSON U ET AL: "TRANSFORMING GROWTH FACTOR (TGF-BETA)-SPECIFIC SIGNALING BY CHIMERIC TGF-BETA TYPE II RECEPTOR WITH INTRACELLULAR DOMAIN OF ACTIVIN TYPE IIB RECEPTOR", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 272, no. 34, 22 August 1997 (1997-08-22), pages 21187 - 21194, XP002934435, ISSN: 0021-9258 *
See also references of WO9946386A1 *
TAKASE M ET AL: "Induction of Smad6 mRNA by bone morphogenetic proteins.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. UNITED STATES 6 MAR 1998, vol. 244, no. 1, 6 March 1998 (1998-03-06), pages 26 - 29, XP002219536, ISSN: 0006-291X *
YINGLING J M ET AL: "Mammalian dwarfins are phosphorylated in response to transforming growth factor beta and are implicated in control of cell growth.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. UNITED STATES 20 AUG 1996, vol. 93, no. 17, 20 August 1996 (1996-08-20), pages 8940 - 8944, XP002219535, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
EP2078752A3 (de) 2009-09-23
WO1999046386A1 (en) 1999-09-16
AU3092899A (en) 1999-09-27
EP2078752A2 (de) 2009-07-15
WO1999046386B1 (en) 1999-10-21
EP1071765A1 (de) 2001-01-31

Similar Documents

Publication Publication Date Title
DE69838473D1 (de) Gerät zur Übertragung von biologischen Signalen
FI990655L (fi) Ihmistelomeraasin katalyyttinen alayksikkö
DE69808929D1 (de) Tragbares und kompaktes retroreflektierende verkehrszeichenanlage
NO20003955L (no) Romlig sammensetning med ultralyd Doppler-signalinformasjon
ATE253371T1 (de) Formulierungen von clarithromycin mit verlängerter wirkstoff-freisetzung
DE59914439D1 (de) Amplitudenmultiplexierung von digitalen Signalen
DE59809750D1 (de) Ultraschallwandler
DE69729641D1 (de) Interferenzverringerung durch gleichzeitige erfassung von kokanalsignalen
EP1558253A4 (de) Piperidinyl-alpha-aminoamid-modulatoren derchemokin-rezeptor-aktivität
TR199801301A3 (tr) Insan semaforin L(H-sema-L) ve diger türlerdeki mütekabil semaforinler.
DE59807074D1 (de) Ultraschallwandler
FI960066A0 (fi) Multiplexerad signalkonvertering
NO981774D0 (no) Fremstilling av L(+) - laktat
BR9711363A (pt) Sintese de bis-indolilmaleimidas
PT1137644E (pt) Derivados de benzofurano sua preparacao e utilizacao
FR2770360B1 (fr) Detection de tonalite et de signaux periodiques
FR2761431B1 (fr) Dispositif de freinage
DE19882623T1 (de) Ultraschall-Umformer
AU3092899A (en) Alk-1 responds to tgf-beta and signals through smad-1 and smad-5
IT1319128B1 (it) Procedimento e dispositivo per prelevare tipo di conducente
ID21769A (id) Komposisi-komposisi cangkokan hasil kopolimerisasi
DE69626356D1 (de) Korrelation von OFDM-Signalen
FR2760626B1 (fr) Dispositif ameliore de prelevement uterin
DE69825806D1 (de) Signalumwandlungsvorrichtung und Informationsaufzeichnungsgerät damit
ATE199653T1 (de) Kombinierter laborkondensator und gefässverbinder

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000925

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20021203

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20040716

17Q First examination report despatched

Effective date: 20040716

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1032245

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20090420